ClinicalTrials.gov record
Completed Early Phase 1 Interventional

N-of-1 Trials for Blood Pressure Medications in Adults

ClinicalTrials.gov ID: NCT02744456

Public ClinicalTrials.gov record NCT02744456. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 7:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Study of N-of-1 Trials of Blood Pressure Medications in Adults With Hypertension

Study identification

NCT ID
NCT02744456
Recruitment status
Completed
Study type
Interventional
Phase
Early Phase 1
Lead sponsor
Columbia University
Other
Enrollment
10 participants

Conditions and interventions

Interventions

  • Amlodipine Drug
  • Hydrochlorothiazide Drug
  • Losartan Drug

Drug

Eligibility (public fields only)

Age range
21 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2014
Primary completion
Aug 30, 2017
Completion
Dec 30, 2017
Last update posted
Mar 25, 2019

2014 – 2017

United States locations

U.S. sites
1
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Columbia University Medical Center New York New York 10032

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02744456, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 25, 2019 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02744456 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →